table of content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Hospital-Acquired Disease Testing Market Size Analysis from 2022 to 2027
1.5.1 Global Hospital-Acquired Disease Testing Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Hospital-Acquired Disease Testing Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Hospital-Acquired Disease Testing Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Hospital-Acquired Disease Testing Industry Impact
Chapter 2 Global Hospital-Acquired Disease Testing Competition by Types, Applications, and Top Regions and Countries
2.1 Global Hospital-Acquired Disease Testing (Volume and Value) by Type
2.1.1 Global Hospital-Acquired Disease Testing Consumption and Market Share by Type (2016-2021)
2.1.2 Global Hospital-Acquired Disease Testing Revenue and Market Share by Type (2016-2021)
2.2 Global Hospital-Acquired Disease Testing (Volume and Value) by Application
2.2.1 Global Hospital-Acquired Disease Testing Consumption and Market Share by Application (2016-2021)
2.2.2 Global Hospital-Acquired Disease Testing Revenue and Market Share by Application (2016-2021)
2.3 Global Hospital-Acquired Disease Testing (Volume and Value) by Regions
2.3.1 Global Hospital-Acquired Disease Testing Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Hospital-Acquired Disease Testing Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Hospital-Acquired Disease Testing Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Hospital-Acquired Disease Testing Consumption by Regions (2016-2021)
4.2 North America Hospital-Acquired Disease Testing Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Hospital-Acquired Disease Testing Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Hospital-Acquired Disease Testing Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Hospital-Acquired Disease Testing Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Hospital-Acquired Disease Testing Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Hospital-Acquired Disease Testing Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Hospital-Acquired Disease Testing Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Hospital-Acquired Disease Testing Sales, Consumption, Export, Import (2016-2021)
4.10 South America Hospital-Acquired Disease Testing Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Hospital-Acquired Disease Testing Market Analysis
5.1 North America Hospital-Acquired Disease Testing Consumption and Value Analysis
5.1.1 North America Hospital-Acquired Disease Testing Market Under COVID-19
5.2 North America Hospital-Acquired Disease Testing Consumption Volume by Types
5.3 North America Hospital-Acquired Disease Testing Consumption Structure by Application
5.4 North America Hospital-Acquired Disease Testing Consumption by Top Countries
5.4.1 United States Hospital-Acquired Disease Testing Consumption Volume from 2016 to 2021
5.4.2 Canada Hospital-Acquired Disease Testing Consumption Volume from 2016 to 2021
5.4.3 Mexico Hospital-Acquired Disease Testing Consumption Volume from 2016 to 2021
Chapter 6 East Asia Hospital-Acquired Disease Testing Market Analysis
6.1 East Asia Hospital-Acquired Disease Testing Consumption and Value Analysis
6.1.1 East Asia Hospital-Acquired Disease Testing Market Under COVID-19
6.2 East Asia Hospital-Acquired Disease Testing Consumption Volume by Types
6.3 East Asia Hospital-Acquired Disease Testing Consumption Structure by Application
6.4 East Asia Hospital-Acquired Disease Testing Consumption by Top Countries
6.4.1 China Hospital-Acquired Disease Testing Consumption Volume from 2016 to 2021
6.4.2 Japan Hospital-Acquired Disease Testing Consumption Volume from 2016 to 2021
6.4.3 South Korea Hospital-Acquired Disease Testing Consumption Volume from 2016 to 2021
Chapter 7 Europe Hospital-Acquired Disease Testing Market Analysis
7.1 Europe Hospital-Acquired Disease Testing Consumption and Value Analysis
7.1.1 Europe Hospital-Acquired Disease Testing Market Under COVID-19
7.2 Europe Hospital-Acquired Disease Testing Consumption Volume by Types
7.3 Europe Hospital-Acquired Disease Testing Consumption Structure by Application
7.4 Europe Hospital-Acquired Disease Testing Consumption by Top Countries
7.4.1 Germany Hospital-Acquired Disease Testing Consumption Volume from 2016 to 2021
7.4.2 UK Hospital-Acquired Disease Testing Consumption Volume from 2016 to 2021
7.4.3 France Hospital-Acquired Disease Testing Consumption Volume from 2016 to 2021
7.4.4 Italy Hospital-Acquired Disease Testing Consumption Volume from 2016 to 2021
7.4.5 Russia Hospital-Acquired Disease Testing Consumption Volume from 2016 to 2021
7.4.6 Spain Hospital-Acquired Disease Testing Consumption Volume from 2016 to 2021
7.4.7 Netherlands Hospital-Acquired Disease Testing Consumption Volume from 2016 to 2021
7.4.8 Switzerland Hospital-Acquired Disease Testing Consumption Volume from 2016 to 2021
7.4.9 Poland Hospital-Acquired Disease Testing Consumption Volume from 2016 to 2021
Chapter 8 South Asia Hospital-Acquired Disease Testing Market Analysis
8.1 South Asia Hospital-Acquired Disease Testing Consumption and Value Analysis
8.1.1 South Asia Hospital-Acquired Disease Testing Market Under COVID-19
8.2 South Asia Hospital-Acquired Disease Testing Consumption Volume by Types
8.3 South Asia Hospital-Acquired Disease Testing Consumption Structure by Application
8.4 South Asia Hospital-Acquired Disease Testing Consumption by Top Countries
8.4.1 India Hospital-Acquired Disease Testing Consumption Volume from 2016 to 2021
8.4.2 Pakistan Hospital-Acquired Disease Testing Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Hospital-Acquired Disease Testing Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Hospital-Acquired Disease Testing Market Analysis
9.1 Southeast Asia Hospital-Acquired Disease Testing Consumption and Value Analysis
9.1.1 Southeast Asia Hospital-Acquired Disease Testing Market Under COVID-19
9.2 Southeast Asia Hospital-Acquired Disease Testing Consumption Volume by Types
9.3 Southeast Asia Hospital-Acquired Disease Testing Consumption Structure by Application
9.4 Southeast Asia Hospital-Acquired Disease Testing Consumption by Top Countries
9.4.1 Indonesia Hospital-Acquired Disease Testing Consumption Volume from 2016 to 2021
9.4.2 Thailand Hospital-Acquired Disease Testing Consumption Volume from 2016 to 2021
9.4.3 Singapore Hospital-Acquired Disease Testing Consumption Volume from 2016 to 2021
9.4.4 Malaysia Hospital-Acquired Disease Testing Consumption Volume from 2016 to 2021
9.4.5 Philippines Hospital-Acquired Disease Testing Consumption Volume from 2016 to 2021
9.4.6 Vietnam Hospital-Acquired Disease Testing Consumption Volume from 2016 to 2021
9.4.7 Myanmar Hospital-Acquired Disease Testing Consumption Volume from 2016 to 2021
Chapter 10 Middle East Hospital-Acquired Disease Testing Market Analysis
10.1 Middle East Hospital-Acquired Disease Testing Consumption and Value Analysis
10.1.1 Middle East Hospital-Acquired Disease Testing Market Under COVID-19
10.2 Middle East Hospital-Acquired Disease Testing Consumption Volume by Types
10.3 Middle East Hospital-Acquired Disease Testing Consumption Structure by Application
10.4 Middle East Hospital-Acquired Disease Testing Consumption by Top Countries
10.4.1 Turkey Hospital-Acquired Disease Testing Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Hospital-Acquired Disease Testing Consumption Volume from 2016 to 2021
10.4.3 Iran Hospital-Acquired Disease Testing Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Hospital-Acquired Disease Testing Consumption Volume from 2016 to 2021
10.4.5 Israel Hospital-Acquired Disease Testing Consumption Volume from 2016 to 2021
10.4.6 Iraq Hospital-Acquired Disease Testing Consumption Volume from 2016 to 2021
10.4.7 Qatar Hospital-Acquired Disease Testing Consumption Volume from 2016 to 2021
10.4.8 Kuwait Hospital-Acquired Disease Testing Consumption Volume from 2016 to 2021
10.4.9 Oman Hospital-Acquired Disease Testing Consumption Volume from 2016 to 2021
Chapter 11 Africa Hospital-Acquired Disease Testing Market Analysis
11.1 Africa Hospital-Acquired Disease Testing Consumption and Value Analysis
11.1.1 Africa Hospital-Acquired Disease Testing Market Under COVID-19
11.2 Africa Hospital-Acquired Disease Testing Consumption Volume by Types
11.3 Africa Hospital-Acquired Disease Testing Consumption Structure by Application
11.4 Africa Hospital-Acquired Disease Testing Consumption by Top Countries
11.4.1 Nigeria Hospital-Acquired Disease Testing Consumption Volume from 2016 to 2021
11.4.2 South Africa Hospital-Acquired Disease Testing Consumption Volume from 2016 to 2021
11.4.3 Egypt Hospital-Acquired Disease Testing Consumption Volume from 2016 to 2021
11.4.4 Algeria Hospital-Acquired Disease Testing Consumption Volume from 2016 to 2021
11.4.5 Morocco Hospital-Acquired Disease Testing Consumption Volume from 2016 to 2021
Chapter 12 Oceania Hospital-Acquired Disease Testing Market Analysis
12.1 Oceania Hospital-Acquired Disease Testing Consumption and Value Analysis
12.2 Oceania Hospital-Acquired Disease Testing Consumption Volume by Types
12.3 Oceania Hospital-Acquired Disease Testing Consumption Structure by Application
12.4 Oceania Hospital-Acquired Disease Testing Consumption by Top Countries
12.4.1 Australia Hospital-Acquired Disease Testing Consumption Volume from 2016 to 2021
12.4.2 New Zealand Hospital-Acquired Disease Testing Consumption Volume from 2016 to 2021
Chapter 13 South America Hospital-Acquired Disease Testing Market Analysis
13.1 South America Hospital-Acquired Disease Testing Consumption and Value Analysis
13.1.1 South America Hospital-Acquired Disease Testing Market Under COVID-19
13.2 South America Hospital-Acquired Disease Testing Consumption Volume by Types
13.3 South America Hospital-Acquired Disease Testing Consumption Structure by Application
13.4 South America Hospital-Acquired Disease Testing Consumption Volume by Major Countries
13.4.1 Brazil Hospital-Acquired Disease Testing Consumption Volume from 2016 to 2021
13.4.2 Argentina Hospital-Acquired Disease Testing Consumption Volume from 2016 to 2021
13.4.3 Columbia Hospital-Acquired Disease Testing Consumption Volume from 2016 to 2021
13.4.4 Chile Hospital-Acquired Disease Testing Consumption Volume from 2016 to 2021
13.4.5 Venezuela Hospital-Acquired Disease Testing Consumption Volume from 2016 to 2021
13.4.6 Peru Hospital-Acquired Disease Testing Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Hospital-Acquired Disease Testing Consumption Volume from 2016 to 2021
13.4.8 Ecuador Hospital-Acquired Disease Testing Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Hospital-Acquired Disease Testing Business
14.1 Diatherix Laboratories
14.1.1 Diatherix Laboratories Company Profile
14.1.2 Diatherix Laboratories Hospital-Acquired Disease Testing Product Specification
14.1.3 Diatherix Laboratories Hospital-Acquired Disease Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Gen-Probe
14.2.1 Gen-Probe Company Profile
14.2.2 Gen-Probe Hospital-Acquired Disease Testing Product Specification
14.2.3 Gen-Probe Hospital-Acquired Disease Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 Qiagen
14.3.1 Qiagen Company Profile
14.3.2 Qiagen Hospital-Acquired Disease Testing Product Specification
14.3.3 Qiagen Hospital-Acquired Disease Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 F. Hoffmann-La Roche
14.4.1 F. Hoffmann-La Roche Company Profile
14.4.2 F. Hoffmann-La Roche Hospital-Acquired Disease Testing Product Specification
14.4.3 F. Hoffmann-La Roche Hospital-Acquired Disease Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Cepheid
14.5.1 Cepheid Company Profile
14.5.2 Cepheid Hospital-Acquired Disease Testing Product Specification
14.5.3 Cepheid Hospital-Acquired Disease Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 Life Technologies Corporation
14.6.1 Life Technologies Corporation Company Profile
14.6.2 Life Technologies Corporation Hospital-Acquired Disease Testing Product Specification
14.6.3 Life Technologies Corporation Hospital-Acquired Disease Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 Meridian Biosciences
14.7.1 Meridian Biosciences Company Profile
14.7.2 Meridian Biosciences Hospital-Acquired Disease Testing Product Specification
14.7.3 Meridian Biosciences Hospital-Acquired Disease Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 Cantel Medical Corporation
14.8.1 Cantel Medical Corporation Company Profile
14.8.2 Cantel Medical Corporation Hospital-Acquired Disease Testing Product Specification
14.8.3 Cantel Medical Corporation Hospital-Acquired Disease Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 Nordion
14.9.1 Nordion Company Profile
14.9.2 Nordion Hospital-Acquired Disease Testing Product Specification
14.9.3 Nordion Hospital-Acquired Disease Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Hospital-Acquired Disease Testing Market Forecast (2022-2027)
15.1 Global Hospital-Acquired Disease Testing Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Hospital-Acquired Disease Testing Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Hospital-Acquired Disease Testing Value and Growth Rate Forecast (2022-2027)
15.2 Global Hospital-Acquired Disease Testing Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Hospital-Acquired Disease Testing Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Hospital-Acquired Disease Testing Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Hospital-Acquired Disease Testing Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Hospital-Acquired Disease Testing Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Hospital-Acquired Disease Testing Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Hospital-Acquired Disease Testing Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Hospital-Acquired Disease Testing Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Hospital-Acquired Disease Testing Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Hospital-Acquired Disease Testing Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Hospital-Acquired Disease Testing Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Hospital-Acquired Disease Testing Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Hospital-Acquired Disease Testing Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Hospital-Acquired Disease Testing Consumption Forecast by Type (2022-2027)
15.3.2 Global Hospital-Acquired Disease Testing Revenue Forecast by Type (2022-2027)
15.3.3 Global Hospital-Acquired Disease Testing Price Forecast by Type (2022-2027)
15.4 Global Hospital-Acquired Disease Testing Consumption Volume Forecast by Application (2022-2027)
15.5 Hospital-Acquired Disease Testing Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
